We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+3.2%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$112M
AUM Growth
+$2.51M
Cap. Flow
-$831K
Cap. Flow %
-0.74%
Top 10 Hldgs %
18.4%
Holding
164
New
24
Increased
48
Reduced
65
Closed
13

Top Sells

Rank Stock Value
1
FCX icon
Freeport-McMoran
FCX
+$1.15M
2
BAX icon
Baxter International
BAX
+$952K
3
NTRS icon
Northern Trust
NTRS
+$934K
4
TGT icon
Target
TGT
+$806K
5
SPXC icon
SPX Corp
SPXC
+$711K

Sector Composition

Rank Sector Weight
1 Industrials 23.8%
2 Healthcare 16.26%
3 Energy 13.01%
4 Financials 11.23%
5 Consumer Staples 10.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DORM icon
51
Dorman Products
DORM
$4.08B
$836K 0.75%
+16,950
New +$925K
GILD icon
52
Gilead Sciences
GILD
$162B
$833K 0.75%
10,050
+6,050
+151% +$471K
ABB
53
DELISTED
ABB Ltd
ABB
$825K 0.74%
35,846
+8,546
+31% +$207K
ARG
54
DELISTED
Airgas Inc
ARG
$817K 0.73%
7,500
+400
+6% +$42.7K
ETN icon
55
Eaton
ETN
$174B
$814K 0.73%
10,550
+1,900
+22% +$141K
CVX icon
56
Chevron
CVX
$371B
$809K 0.72%
6,200
-1,125
-15% -$140K
J icon
57
Jacobs Solutions
J
$16.9B
$809K 0.72%
18,346
+8,221
+81% +$391K
TIBX
58
DELISTED
TIBCO SOFTWARE INC
TIBX
$800K 0.72%
39,650
-2,250
-5% -$44.9K
WST icon
59
West Pharmaceutical
WST
$24.5B
$793K 0.71%
+18,806
New +$805K
K
60
DELISTED
Kellanova
K
$770K 0.69%
12,485
-214
-2% -$13.4K
ABT icon
61
Abbott
ABT
$187B
$769K 0.69%
18,808
-500
-3% -$19.6K
CSX icon
62
CSX Corp
CSX
$93.9B
$769K 0.69%
74,835
-58,680
-44% -$571K
URI icon
63
United Rentals
URI
$72.4B
$759K 0.68%
7,250
-2,550
-26% -$249K
AVT icon
64
Avnet
AVT
$7.94B
$747K 0.67%
16,850
-10,050
-37% -$442K
CAG icon
65
Conagra Brands
CAG
$7.11B
$726K 0.65%
+31,418
New +$760K
FAST icon
66
Fastenal
FAST
$58.3B
$725K 0.65%
58,600
-2,300
-4% -$28.4K
NKE icon
67
Nike
NKE
$62.3B
$721K 0.65%
18,600
+2,000
+12% +$74.4K
MCD icon
68
McDonald's
MCD
$196B
$694K 0.62%
6,885
LULU icon
69
lululemon athletica
LULU
$14.2B
$691K 0.62%
17,075
-1,200
-7% -$54.7K
BRK.B icon
70
Berkshire Hathaway Class B
BRK.B
$1.13T
$674K 0.6%
5,323
-99
-2% -$12.5K
CSCO icon
71
Cisco
CSCO
$476B
$673K 0.6%
27,075
-4,200
-13% -$100K
SYY icon
72
Sysco
SYY
$40.4B
$670K 0.6%
17,900
+2,100
+13% +$77.1K
LECO icon
73
Lincoln Electric
LECO
$15.2B
$660K 0.59%
+9,450
New +$641K
AGU
74
DELISTED
Agrium
AGU
$641K 0.57%
+7,000
New +$649K
MMM icon
75
3M
MMM
$93.2B
$631K 0.57%
5,272

Similar funds

New England Research & Management's Q2 2014 Portfolio in Review

As of Q2 2014, New England Research & Management held 164 positions worth $112M, up 2.3% from $109M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

New England Research & Management's Q2 2014 filing shows 24 new, 48 increased, 65 reduced and 13 closed positions. Its largest new stake was Dorman Products: 16,950 shares worth $836K. The largest sale was Freeport-McMoran, an estimated $1.15M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Energy.

  • New England Research & Management's largest Q2 2014 buy was Dorman Products: 16,950 shares worth $836K.
  • New England Research & Management added most to Procter & Gamble in Q2 2014, an estimated $778K increase.
  • New England Research & Management's biggest Q2 2014 reduction was Baxter International, cutting an estimated $952K.
  • New England Research & Management fully exited Freeport-McMoran in Q2 2014, selling an estimated $1.15M.
  • New England Research & Management's ten largest holdings make up 18% of its $112M portfolio in Q2 2014.
  • New England Research & Management opened 24 new positions and closed 13 in Q2 2014.
  • New England Research & Management's portfolio value rose 2.3% quarter-over-quarter to $112M.

Based on New England Research & Management's 13F filing for Q2 2014, filed 1 Jul 2014.